Kittens

Fevac 3 in 1 Breeders multi dose 10ml vial (600g)
		QTY:
Fevac 3  Composition Inactivated vaccine prepared from feline panleucopenia (feline enteritis) virus, feline rhinotracheitis virus (feline herpesvirus type 1) and feline calicivirus grown in a continuous feline cell line. Contains a water soluble adjuvant to enhance immune response.  Indications Active immunisation of cats against feline panleucopenia (feline enteritis) virus and feline respiratory disease due to feline herpesvirus type 1 or calicivirus.  Precautions Vaccinate only healthy cats or kittens with normal temperatures. Animals undergoing treatment with immunosuppressive drugs should be vaccinated with caution. Studies to support the use of the product in pregnant queens have not been conducted. Disposal. Dispose of empty containers by wrapping in paper and putting in garbage. Empty syringes and needles should immediately be placed into a designated and appropriately labelled sharps container.  Adverse Reactions As it is an inactivated vaccine, untoward systemic effects are uncommon and the vaccine may be used in pregnant queens. Though it is seldom apparent, the vaccine produces a temporary local reaction.  Dosage and Administration Shake the vial well to obtain a uniform suspension of vaccine before administration. The entire contents of the vial should be used immediately after opening. The vaccine may be administered either intramuscularly (in the thigh) or subcutaneously. Each vial contains a single dose (1 mL) of vaccine. Recommended vaccination program. Fevac 3 Vaccine can be used on its own or as part of a standard vaccination program. Primary immunisation for cats aged 8 weeks and older consists of two 1 mL doses of the vaccine given at an interval of three to four weeks. It is also recommended that an annual booster with a single dose of vaccine be administered. Immunisation should be completed at least two weeks prior to probable exposure (e.g. at cat shows, in boarding catteries or during hospitalisation). Give a booster dose every 12 months and consider before times of probable heavy challenge if more than six months have elapsed since the last dose of vaccine. Maternally derived antibody persists in kittens for varying periods and may interfere with the response to vaccination. Vaccinate kittens at 10 and 14 weeks of age. Give kittens receiving their first dose at less than 10 weeks of age a third dose three to four weeks after the second to ensure maximum protection. It has been shown that seronegative kittens immunised with two doses of Fevac 3 develop levels of antibody to all three components of the vaccine sufficient to withstand challenge with virulent virus. Protective immunity to each component is attained two weeks after completion of the immunisation course. Serum antibodies have been shown to persist for 6 to 12 months following two doses of vaccine. Annual booster doses of Fevac 3 are recommended.